Identification of Candida Species and Its Antifungal Susceptibility from Various Clinical Samples

[1]. Chakrabarti A, Sood P, Shivaprakash M, Rudramurthy, Chen S, Kaur H, Kapoor M, et al (2014). Incidence, characteristics and outcome
of ICU acquired candidemia in India. Intensive Care Med; DOI 10.1007/s00134-014-3603-2.
[2]. Pfaller MA (2012). Antifungal drug resistance: mechanism, epidemiology and consequences for treatment. The American Journal of Medicine;
125:3-13.
[3]. Wang H, Xu YC, Hsueh PR (2016). Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-
Pacific region. Future Microbiology ;11 (11) : 1461-1477.
[4]. Joseph K, Ameena KK, George AT. A study on proportion, speciation and antifungal resistance pattern of the Candida isolates in a tertiary care
hospital of North Kerala. Int J Curr Microbiol App Sci. 2017;6(5):434-39.
[5]. Goel R, Singh S, Gill AK, Kaur A, Kaur I. Speciation, characterisation and antifungal susceptibility pattern of Candida species. Int J Contemp
Med.2018;5(5):01-04.
[6]. Sharma, S., Isolation, Speciation and Characterization of Candida Spe cie s in Clinical Isolates. Int. J. Curr. Microbiol. App. Sci, 2017. 6(7): p. 404-
413.
[7]. Khandari KC, Rama KM. Clinical and laboratory studies on c ut a neous Candidiasis. Indian J Dermatol Venereol Leprol. 1969;35(2):102-07.
[8]. Gopi A, Murthy NS. Presumptive identification of Candida species by using Chromogenic agar in comparison with yeast identification protocols in
a tertiary care hospital. J Evid Based Med Healthc. 2014;1(13):1604-13.
[9]. Shaik N, Penmetcha U, Myneni RB, Yarlagadda P, Singamsetty S. A study of identification and antifungal susceptibility pattern of Candida species
isolated from various clinical specimens in a tertiary care teaching hospital, Chinakakani, Guntur, Andhra Pradesh, South India. Int J Curr
Microbiol App Sci. 2016;5(7):71-91.
[10]. Chongtham UR, Athokpam DC, Singh RA. Isolation, identification and antifungal susceptibility testing of Candida species: A cross-sectional study
from Manipur, India. J Clin Diagnostic Res. 2022 Apr 1;16:9-14.
[11]. Pandita I, Wyawahare AS, Mulay MV, Hussain T, Kulkarn S. Speciation and antifungal susceptibility pattern of Candida isolates from various clinical
specimens at a tertiary care hospital, Maharashtra. Int J Adv Res.2019;7(10):244-50.
[12]. Jayalakshmi L, Ratna Kumari G, Samson SH. Isolation, speciation and antifungal susceptibility testing of Candida from clinical specimens at a
tertiary care hospital. Sch J App Med Sci. 2014;2:3193-98.
[13]. Deepthi KN, Menon AR, Nair PK. Identification of Candida species from clinical isolates and their antifungal susceptibility pattern. J Evolution Med
Dent Sci. 2020;9(24):1813-17. Doi: 10.14260/jemds/2020/396.
[14]. Chakraborty M, Banu H, Gupta MK. Epidemiology and antifungal susceptibility of Candida species causing blood stream infections: An eastern
India perspective. J Assoc Physicians India. 2021;69(8):11-12. PMID: 34472809.
[15]. Sabhapandit D, Lyngdoh WV, Bora I, Prasad A, Debnath K, Elantamilan D. Prevalence of non-albicans Candidaemia in a tertiary care hospital in
Northeast India. Int J Med Sci Public Health. 2017;6(11):1620-25.
[16]. Gade N, Neral A, Monga N, Aradhey P, Singh R, Barapatre R, et al. Antifungal susceptibility pattern of clinical isolates of Candida from a tertiary
care hospital in Chhattisgarh, India. Saudi J Pathol Microbiol.2019;4(12):906-13.